AVRO
Price:
$1.4
Market Cap:
$5.24M
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter ...[Read more]
Industry
Biotechnology
IPO Date
2018-06-21
Stock Exchange
NASDAQ
Ticker
AVRO
According to AVROBIO, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 26.17. This represents a change of 55.23% compared to the average of 16.86 of the last 4 quarters.
The mean historical Current Ratio of AVROBIO, Inc. over the last ten years is 10.63. The current 26.17 Current Ratio has changed 24.53% with respect to the historical average. Over the past ten years (40 quarters), AVRO's Current Ratio was at its highest in in the March 2024 quarter at 26.17. The Current Ratio was at its lowest in in the March 2017 quarter at 0.
Average
10.63
Median
11.27
Minimum
2.40
Maximum
16.09
Discovering the peaks and valleys of AVROBIO, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 410.15%
Maximum Annual Current Ratio = 16.09
Minimum Annual Increase = -60.17%
Minimum Annual Current Ratio = 2.40
Year | Current Ratio | Change |
---|---|---|
2023 | 15.78 | 91.80% |
2022 | 8.23 | -19.92% |
2021 | 10.27 | -36.14% |
2020 | 16.09 | 15.21% |
2019 | 13.96 | 13.89% |
2018 | 12.26 | 410.15% |
2017 | 2.40 | -60.17% |
The current Current Ratio of AVROBIO, Inc. (AVRO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
11.43
5-year avg
12.87
10-year avg
10.63
AVROBIO, Inc.’s Current Ratio is greater than CohBar, Inc. (4.16), greater than Ocean Biomedical, Inc. (0.03), greater than Enveric Biosciences, Inc. (7.37), less than Elevation Oncology, Inc. (41.10), greater than Zura Bio Limited (12.57), greater than Hepion Pharmaceuticals, Inc. (5.62), greater than eFFECTOR Therapeutics, Inc. (1.03),
Company | Current Ratio | Market cap |
---|---|---|
4.16 | $1.25M | |
0.03 | $33.96M | |
7.37 | $4.53M | |
41.10 | $36.94M | |
12.57 | $230.86M | |
5.62 | $4.20M | |
1.03 | $188.18K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AVROBIO, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AVROBIO, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is AVROBIO, Inc.'s Current Ratio?
How is the Current Ratio calculated for AVROBIO, Inc. (AVRO)?
What is the highest Current Ratio for AVROBIO, Inc. (AVRO)?
What is the 3-year average Current Ratio for AVROBIO, Inc. (AVRO)?
What is the 5-year average Current Ratio for AVROBIO, Inc. (AVRO)?
How does the current Current Ratio for AVROBIO, Inc. (AVRO) compare to its historical average?